MTHFR and colorectal cancer: By contrast, most studies containing advanced colorectal cancer patients receiving 5-FU associated with irinotecan or oxaliplatin failed to show a link between the two MTHFR polymorphisms (677C>T and 1298A>C) and RR or survival [11, 20, 21].